A Bioequivalence Study of Mirikizumab (LY3074828) Solution in Healthy Participants
Clinical trial NCT05644353 · COMPLETED
Trial details
- NCT number
- NCT05644353
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-05
- Primary completion
- 2023-05-25
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.